Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation.
Jennifer D MotterAllan B MassieJacqueline M Garonzik-WangRuth M PfeifferKelly J YuDorry L SegevEric A Engels
Published in: Transplantation direct (2023)
These findings indicate that the risk of cancer is not increased for ILDKTr compared with CLDKTr. The possible elevation in colorectal cancer risk is unexplained and might suggest a need for tailored screening or prevention.